CHESTERFIELD, Mo., Feb. 21 /PRNewswire-FirstCall/ -- Reliv' International,
Inc. (Nasdaq: RELV) announced today that it has filed a registration statement
on Form S-3 with the Securities and Exchange Commission relating to an
underwritten public offering of 2,000,000 shares of its common stock. The
Company proposes to issue 1,200,000 shares of its common stock and the
remaining 800,000 shares are proposed to be offered by selling stockholders.
In connection with the offering, some of the selling stockholders expect to
grant the underwriters a 30-day option to purchase up to 300,000 additional
shares of Reliv's common stock to cover over-allotments, if any.
Reliv' intends to use the net proceeds for the repayment of debt and for
general corporate purposes, including working capital, continued domestic and
international growth, and for possible product acquisitions. The Company will
not receive any proceeds from the sale of common stock by the selling
stockholders.
Canaccord Adams will act as the sole book-running manager of this
offering. Avondale Partners and The Seidler Companies Incorporated will act
as co-managers.
A registration statement relating to these securities has been filed with
the Securities and Exchange Commission but has not yet become effective.
These securities may not be sold nor may offers to buy be accepted prior to
the time the registration statement becomes effective. This press release
shall not constitute an offer to sell or the solicitation of an offer to buy
any of the securities described herein, nor shall there be any sale of these
securities in any state or jurisdiction in which such offer, solicitation or
sale would be unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction. The offering of the shares
of common stock may be made only by means of the prospectus, copies of which
can be obtained from Canaccord Adams, Attn: Syndicate Dept., 99 High St., 11th
Fl., Boston, MA 02110, when available.
About Reliv' International, Inc.
Reliv' International, Inc. is a developer, manufacturer and marketer of a
proprietary line of nutritional supplements, addressing basic nutrition,
specific wellness needs, weight management and sports nutrition. It sells its
products through an international network marketing system using independent
distributors. Reliv' has sold products in the United States since 1988 and in
selected international markets since 1991.
Statements made in this release that are not historical facts are
"forward-looking" statements (as defined in the Private Securities Litigation
Reform Act of 1995) that involve risks and uncertainties and are subject to
change at any time. These forward-looking statements may include, but are not
limited to, statements containing words such as "may," "should," "could,"
"would," "expect," "plan," "anticipate," "believe," "estimate," "predict,"
"potential," "continue," or similar expressions.
Factors that could cause actual results to differ are identified in the
public filings made by Reliv' with the Securities and Exchange Commission.
More information on factors that could affect Reliv's business and financial
results are included in its public filings made with the Securities and
Exchange Commission, including its Annual Report on Form 10-K and Quarterly
Reports on Form 10-Q, copies of which are available on the Company's web site,
http://www.reliv.com .
SOURCE Reliv' International, Inc.
 back to top
Related links:
http://www.reliv.com
Company News On-Call:
http://www.prnewswire.com/comp/103123.html
CONTACT:
Steve Albright, CFO of Reliv' International,
Inc., +1-636-733-1305
|
